Our findings align with those of recent studies emphasizing the significance of immune-related genes, specifically GZMA, GZMB, GZMK and PRF1, in cancer pathogenesis and clinical outcomes [8,38,39,40,41,42,43]. This evidence concerns the gene GZMK and cancer.